| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
July 31, 2023 |
|
|
| |
|
|
| |
|
|
|
Xtalks, online
2023 -8-29
In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making. Understanding the ADME properties and DDI risks of a compound avoids unnecessary clinical studies, costs, delays and more.
This webinar will provide insights at a high-level related to regulatory drivers, investigatory objectives and practical concerns for such studies. Participants will gain insight into the specific needs and utility for in vitro ADME and DDI investigations in the drug development process. Regulatory expectations will be reviewed as will points of particular interest for enabling successful achievement of investigatory goals and submissions.
Register to gain access to these valuable insights and the opportunity to explore ADME and drug-drug interaction considerations in drug development.
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Andrew G. Taylor, PhD, ADME Technical Sales Specialist, BioIVT
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2023 -8-29
|
|
|
|
|
|
|
|
Registration:
|
|
Free registration
|
|
|
E-mail:
|
|
ajuurinen@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|